Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

The combination therapy was effective and well-tolerated, especially in young patients.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Combining epinephrine with a steroid may help regrow hair in severe alopecia areata cases.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

The model can effectively test gene functions and drug responses in human skin.

Topical treatments helped a child with Down syndrome and severe hair loss regrow most of his hair.

Topical calcipotriol successfully treated hair loss in three patients with Alopecia Totalis.

Laser therapy might help regrow hair in alopecia totalis better than steroids alone.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Low dose methotrexate does not increase hair fall and may reduce it.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Secukinumab can cause hair loss, which may improve after stopping the medication.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

The model and estimator can predict drug exposure in kidney transplant patients well.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Minoxidil effectively treats hair loss, but use cautiously and monitor side effects.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Alopecia areata treatment varies, with no optimal method established yet.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.